Jazz Pharma basks in praise as it adds CNS drugs in Azur acquisition #pharma #services

Posted On Dec 5 2017 by

#azur pharma # Jazz Pharma basks in praise as it adds CNS drugs in Azur acquisition Occasionally cited as a potential takeover target, Jazz Pharmaceuticals ($JAZZ) is in the news this morning with a takeover of its own. The biotech says it has struck an all-stock deal to acquire Dublin, Ireland-based Azur Pharma, adding new CNS drugs to its list of approved drugs. Once the proposed deal goes through, the combined operation is expected to have $475 million in annual revenue. Jazz CEO Bruce Cozadd told analysts this morning that the developer–which ran into a regulatory rejection last year–has been …


Jazz Pharma basks in praise as it adds CNS drugs in Azur acquisition #pharma #gossip

Posted On Nov 10 2017 by

#azur pharma # Jazz Pharma basks in praise as it adds CNS drugs in Azur acquisition Occasionally cited as a potential takeover target, Jazz Pharmaceuticals ($JAZZ) is in the news this morning with a takeover of its own. The biotech says it has struck an all-stock deal to acquire Dublin, Ireland-based Azur Pharma, adding new CNS drugs to its list of approved drugs. Once the proposed deal goes through, the combined operation is expected to have $475 million in annual revenue. Jazz CEO Bruce Cozadd told analysts this morning that the developer–which ran into a regulatory rejection last year–has been …


Jazz moves into Ireland with Azur buy – RT – News #pharmaceutical #business

Posted On Sep 10 2017 by

#azur pharma # Jazz moves into Ireland with Azur buy Thursday 19 January 2012 11.26 US company Jazz Pharmaceuticals has bought Irish firm Azur Pharma in a deal that creates a €1.5 billion specialty drug company headquartered in Dublin. Now named Jazz Pharmaceuticals plc, it has about 430 employees – 20 in Dublin – with offices also in Philadelphia and Palo Alto. One of the founders of Azur was former Elan executive Seamus Mulligan. Azur shareholders will own just over 20% of the new group, with Jazz shareholders owning the remainder of the combined firm. RELATED AUDIO VIDEO Azur Pharma …


Jazz Pharma basks in praise as it adds CNS drugs in Azur acquisition #market #research #companies

Posted On Sep 10 2017 by

#azur pharma # Jazz Pharma basks in praise as it adds CNS drugs in Azur acquisition Occasionally cited as a potential takeover target, Jazz Pharmaceuticals ($JAZZ) is in the news this morning with a takeover of its own. The biotech says it has struck an all-stock deal to acquire Dublin, Ireland-based Azur Pharma, adding new CNS drugs to its list of approved drugs. Once the proposed deal goes through, the combined operation is expected to have $475 million in annual revenue. Jazz CEO Bruce Cozadd told analysts this morning that the developer–which ran into a regulatory rejection last year–has been …


Jazz moves into Ireland with Azur buy – RT – News #pharma #packaging #solutions

Posted On Aug 31 2017 by

#azur pharma # Jazz moves into Ireland with Azur buy Thursday 19 January 2012 11.26 US company Jazz Pharmaceuticals has bought Irish firm Azur Pharma in a deal that creates a €1.5 billion specialty drug company headquartered in Dublin. Now named Jazz Pharmaceuticals plc, it has about 430 employees – 20 in Dublin – with offices also in Philadelphia and Palo Alto. One of the founders of Azur was former Elan executive Seamus Mulligan. Azur shareholders will own just over 20% of the new group, with Jazz shareholders owning the remainder of the combined firm. RELATED AUDIO VIDEO Azur Pharma …


Jazz Pharma basks in praise as it adds CNS drugs in Azur acquisition #vital #pharma

Posted On Aug 11 2017 by

#azur pharma # Jazz Pharma basks in praise as it adds CNS drugs in Azur acquisition Occasionally cited as a potential takeover target, Jazz Pharmaceuticals ($JAZZ) is in the news this morning with a takeover of its own. The biotech says it has struck an all-stock deal to acquire Dublin, Ireland-based Azur Pharma, adding new CNS drugs to its list of approved drugs. Once the proposed deal goes through, the combined operation is expected to have $475 million in annual revenue. Jazz CEO Bruce Cozadd told analysts this morning that the developer–which ran into a regulatory rejection last year–has been …


Jazz moves into Ireland with Azur buy – RT – News #sun #pharma

Posted On Jul 26 2017 by

#azur pharma # Jazz moves into Ireland with Azur buy Thursday 19 January 2012 11.26 US company Jazz Pharmaceuticals has bought Irish firm Azur Pharma in a deal that creates a €1.5 billion specialty drug company headquartered in Dublin. Now named Jazz Pharmaceuticals plc, it has about 430 employees – 20 in Dublin – with offices also in Philadelphia and Palo Alto. One of the founders of Azur was former Elan executive Seamus Mulligan. Azur shareholders will own just over 20% of the new group, with Jazz shareholders owning the remainder of the combined firm. RELATED AUDIO VIDEO Azur Pharma …


Jazz Pharmaceuticals to acquire Azur Pharma #fdc #pharma

Posted On Jul 12 2017 by

#azur pharma # Jazz Pharmaceuticals to acquire Azur Pharma James Fleishman, a former sales manager at Primary Global Research LLC, right, leaves federal court with attorney Ethan Balogh in New York, U.S. on Jan. 4, 2011. Fleishman and two ex-consultants for expert-networking firm Primary Global Research LLC were released on bail after a hearing before a New York federal judge as part of their prosecution in a nationwide probe of hedge fund insider trading. Photographer: Jeremy Bales/Bloomberg *** Local Caption *** James Fleishman; Ethan Balogh James Fleishman, a former sales manager at Primary Global Research LLC, right, leaves federal court …


Jazz Pharma basks in praise as it adds CNS drugs in Azur acquisition #pharmaceutical #companies #in #atlanta

Posted On Jul 12 2017 by

#azur pharma # Jazz Pharma basks in praise as it adds CNS drugs in Azur acquisition Occasionally cited as a potential takeover target, Jazz Pharmaceuticals ($JAZZ) is in the news this morning with a takeover of its own. The biotech says it has struck an all-stock deal to acquire Dublin, Ireland-based Azur Pharma, adding new CNS drugs to its list of approved drugs. Once the proposed deal goes through, the combined operation is expected to have $475 million in annual revenue. Jazz CEO Bruce Cozadd told analysts this morning that the developer–which ran into a regulatory rejection last year–has been …


Jazz Pharmaceuticals to acquire Azur Pharma #zosano #pharma

Posted On Jul 6 2017 by

#azur pharma # Jazz Pharmaceuticals to acquire Azur Pharma James Fleishman, a former sales manager at Primary Global Research LLC, right, leaves federal court with attorney Ethan Balogh in New York, U.S. on Jan. 4, 2011. Fleishman and two ex-consultants for expert-networking firm Primary Global Research LLC were released on bail after a hearing before a New York federal judge as part of their prosecution in a nationwide probe of hedge fund insider trading. Photographer: Jeremy Bales/Bloomberg *** Local Caption *** James Fleishman; Ethan Balogh James Fleishman, a former sales manager at Primary Global Research LLC, right, leaves federal court …